The effects of radix curcumae extract on expressions of VEGF, COX-2 and PCNA in gastric mucosa of rats fed with MNNG

Current Pharmaceutical Biotechnology

Volumn 11, Issue 3, 2010, Pages 313-317

  Lu, Bin ^a   Yu, Linfeng ^a   Xu, Lei ^a   Chen, Hanqing ^a   Zhang, Lu ^a   Zeng, Yanjun ^b  

^a ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Cyclooxygenase 2 (COX 2); Gastric cancer; N methyl N nitro N nitrosoguanidine (MNNG); Proliferating cell nuclear antigen (PCNA); Radix curcumae; Vascular endothelial growth factor (VEGF)

Indexed keywords

CELECOXIB; CYCLINE; CYCLOOXYGENASE 2; METHYLNITRONITROSOGUANIDINE; PLANT EXTRACT; RADIX CURCUMAE EXTRACT; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; DOWN REGULATION; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; OPTICAL DENSITY; PROTEIN EXPRESSION; RAT; STOMACH CANCER; STOMACH MUCOSA;

ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOGENS; CURCUMA; CYCLOOXYGENASE 2; GENE EXPRESSION; MALE; METHYLNITRONITROSOGUANIDINE; PLANT EXTRACTS; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, WISTAR; STOMACH NEOPLASMS; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

RATTUS; RATTUS NORVEGICUS;

EID: 77950908902     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920110791111915     Document Type: Article

References (22)

1. Whelan, S.L.; Parkin, D.M.; Masuyer, E. Trends in Cancer Incidence and Mortality; IARC Scientific Publications: Lyon, France, 1993.
2. Huang, M.T.; Lou, Y.R.; Ma, W.; Newmark, H.L.; Reuhl, K.R.; Conney, A.H. Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res., 1994, 54(22), 5841-5847.
3. Kawamori, T.; Lubet, R.; Steele, V.E.; Kelloff, G.J.; Kaskey, R.B.; Rao, C.V.; Reddy, B.S. Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res., 1999, 59(3), 597-601.
4. Kuttan, R.; Bhanumathy, P.; Nirmala, K.; George, M.C. Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett., 1985, 29(2), 197-202.
5. Lu, B.; Xu, L.; Yu, L.F.; Zhang, L. Extract of radix curcumae prevents gastric cancer in rats. Digestion, 2008, 77(2), 87-91. (Pubitemid 351556385)
6. Mattern, J.; Koomägi, R.; Volm, M. Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma. Br. J. Cancer, 1996, 73(7), 931-934. (Pubitemid 26110166)
7. Lin, J.K.; Lin-Shiau, S.Y. Mechanisms of cancer chemoprevention by curcumin. Proc. Natl. Sci. Counc. Repub. China B, 2001, 25(2), 59-66.
8. Goel, A.; Boland, C.R.; Chauhan, D.P. Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells. Cancer Lett., 2001, 172(2), 111-118. (Pubitemid 32889704)
9. Folkman, J.; Shing, Y. Angiogenesis. J. Biol. Chem., 1992, 267(16), 10931-10934.
10. Ferrara, N.; Henzel, W.J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun., 1989, 161(2), 851-858.
11. Book, A.A.; Ranganathan, S.; Abounader, R.; Rosen, E.; Laterra, J. Scatter factor/hepatocyte growth factor gene transfer increases rat blood-glioma barrier permeability. Brain Res., 1999, 833(2), 173-180.
12. Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst., 1990, 82(1), 4-6.
13. Maeda, K.; Chung, Y.S.; Ogawa, Y.; Takatsuka, S.; Kang, S.M.; Ogawa, M.; Sawada, T.; Sowa, M. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer, 1996, 77(5), 858-863.
14. Wang, J.L.; Lu, B.; Ni, G.B.; Ma, L.; Xu, Y. Effect of common gurmeric on vascular endothelial growth factor and microvessel density in athymic mouse model transplanted with human gastric carcinoma. Tumor, 2005, 25(1), 55-57.
15. McMurray, R.W.; Hardy, K.J. Cox-2 inhibitors: today and tomorrow. Am. J. Med. Sci., 2002, 323(4), 181-189.
16. Lee, T.L.; Leung, W.K.; Lau, J.Y.; Tong, J.H.; Ng, E.K.; Chan, F.K.; Chung, S.C.; Sung, J.J.; To, K.F. Inverse association between cyclooxygenase-2 overexpression and microsatellite instability in gastric cancer. Cancer Lett., 2001, 168(2), 133-140.
17. Sawaoka, H.; Kawano, S.; Tsuji, S.; Tsujii, M.; Murata, H.; Hori, M. Effects of NSAIDs on proliferation of gastric cancer cells in vitro: possible implication of cyclooxygenase-2 in cancer development. J. Clin. Gastroenterol., 1998, 27 (Suppl 1), S47-52.
18. Hu, P.J.; Yu, J.; Zeng, Z.R.; Leung, W.K.; Lin, H.L.; Tang, B.D.; Bai, A.H.; Sung J.J. Chemoprevention of gastric cancer by celecoxib in rats. Gut, 2004, 53(2), 195-200.
19. Waga, S.; Hannon, G.J.; Beach, D.; Stillman, B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature, 1994, 369(6481), 574-578.
20. De-Marzo, A.M.; Marchi, V.L.; Yang, E.S.; Veeraswamy, R.; Lin, X.; Nelson W.G. Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis. Cancer Res., 1999, 59(16), 3855-3860.
21. Koga, T.; Shibahara, K.; Kabashima, A.; Sumiyoshi, Y.; Kimura, Y.; Takahashi, I.; Kakeji, Y.; Maehara, Y. Overexpression of cyclooxygenase-2 and tumor angiogenesis in human gastric cancer. Hepatogastroenterology, 2004, 51(60), 1626-1630.
22. Leung, W.K.; To, K.F.; Go, M.Y.; Chan, K.K.; Chan, F.K.; Ng, E.K.; Chung, S.C.; Sung, J.J. Cyclooxygenase-2 upregulates vascular endothelial growth factor expression and angiogenesis in human gastric carcinoma. Int. J. Oncol., 2003, 23(5), 1317-1322.